Changes in Breast 3D Ultrasound Measurements Using Toremifene

Phase 3

Completed

• Conditions: Circulatory; Change
• Interventions: Drug: Toremifene

• Registration Number: NCT01417754
• Lead Sponsor: Satakunta Central Hospital

Brief Summary

To investigate if there are detectable changes in volume and circulation in breasts of healthy volunteers using toremifene 20 mg in luteal phase of the menstruation cycle versus nonmedicated cycle.

Detailed Description

20 women were participated to this trial.

Study Timeline

• Study Start: 2010-09
• Primary Completion: 2010-11
• Study Completion: 2011-06
• Study First Submitted: 2011-07-28
• Status Verified: 2011-08
• Study First Submitted QC: 2011-08-15
• Study First Posted: 2011-08-16
• Last Update Submitted: 2011-08-22
• Last Update Posted: 2011-08-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 20

Inclusion Criteria

• age 25-45 healthy person
• regular menstrual cycles
• safe contraception(for example sterilization or condom)

Exclusion Criteria

• gynecological or other type of cancer
• hormonal contraception
• pregnancy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Toremifene	Toremifene	-

Primary Outcome Measures

Name	Time	Method
circulation changes of the breast	cycle day 23 to 26

Trial Locations

Locations (1)

Porin Lääkäritalo; 🇫🇮 Pori, Finland